MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jrr/rrag034

Медицинская библиотека · Journal of radiation research · 2026

Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective study.

Miyazaki Tomohiko, Yasuda Koichi, Taguchi Hiroshi, Minatogawa Hideki, Inoue Tetsuya, Takashina Rikiya, Otsuka Manami, Nakazato Keiji, Nishiyama Noriaki, Kobashi Keiji, Otake Izuru, Sakakibara-Konishi Jun, Oizumi Satoshi, Kikuchi Hajime, Hashimoto Takayuki, Aoyama Hidefumi

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

This study aimed to identify the optimal combination of heart and lung dose parameters associated with overall survival (OS) in patients with locally advanced non-small cell lung carcinoma (LA-NSCLC) receiving radiotherapy. Data from 278 patients treated definitively for LA-NSCLC at three institutions between 1 April 2013 and 31 October 2021 were retrospectively analyzed. Lung and heart dose parameters were categorized into high- or low-dose groups based on predefined thresholds for subsequent analysis. Univariable analysis of OS was conducted for all dose group combinations. The combination with the lowest P-value was identified as the most promising and included in the multivariable analysis along with other clinical factors. The combinations of mean heart dose (MHD)/lung V40 (LV40) ('Vxx' denotes the percentage of organ volume receiving ≥xx Gy) and heart V5 (HV5)/LV40 yielded the lowest P-values (P = 0.021). The thresholds for these dose parameters were MHD ≤24.4 Gy, HV5 ≤63% and LV40 ≤7.7%, respectively. Multivariable analysis incorporating clinical factors identified age ≥65 years (HR: 2.06, P = 0.002), performance status ≥1 (Hazard ratio [HR]: 1.68, P = 0.024), chemoradiotherapy (HR: 0.28, P < 0.001), current smoking history (HR: 2.21, P < 0.001), gross tumor volume (HR: 1.43, P = 0.007) and the MHD/LV40 combination (HR: 2.35, P = 0.003) as independent prognostic factors. While exploratory, this study highlights the clinical significance of the MHD/LV40 combination as a prognostic factor; integrating these parameters radiotherapy for LA-NSCLC may improve patient outcomes.

Для цитирования: Miyazaki Tomohiko, Yasuda Koichi, Taguchi Hiroshi, Minatogawa Hideki, Inoue Tetsuya, Takashina Rikiya, Otsuka Manami, Nakazato Keiji, Nishiyama Noriaki, Kobashi Keiji, Otake Izuru, Sakakibara-Konishi Jun, Oizumi Satoshi, Kikuchi Hajime, Hashimoto Takayuki, Aoyama Hidefumi. Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective study.. Journal of radiation research. 2026. DOI: 10.1093/jrr/rrag034.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.